PROCTER & GAMBLE Co
PGNYSE · SIC 2840
$149.98
↓ -1.0%Jul 17 close · end-of-day
Price
1Y↑ +0.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$362.4B
Enterprise Value
$399.5B
P/E
21.9
P/S
4.2
P/B
6.6
EV/EBITDA
17.2
PEG
5.7
FCF Yield
4.2%
Dividend Yield
2.8%
Revenue (TTM)
$86.7B
Net Income (TTM)
$16.6B
Free Cash Flow (TTM)
$15.0B
Gross Margin
—
Operating Margin
23.2%
Net Margin
19.2%
ROE
30.4%
ROIC
17.3%
Debt / Equity
0.7
Net Cash
-$37.0B
Return 1Y
-0.9%
Company profile
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. The Beauty segment offers conditioners, shampoos, styling aids, and treatments; and antiperspirants and deodorants, personal cleansing, and skin care products under the Head & Shoulders, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, and Secret brands.
- CEO
- Jon R. Moeller
- Sector
- Manufacturing
- Industry
- Consumer Goods
- Employees
- 106,000
- Headquarters
- Ohio
- Website
- pginvestor.com
Management & directors
- Francisco Ma. FatimaCEO - Baby, Fem & Family Care
- Whaley Susan StreetChief Legal Officer & Secy
- Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
- Coombe Gary ACEO - Grooming
- Moeller Jon RExec. Chairman of the Board
- Purushothaman BalajiChief Human Resources Officer
- Pritchard Marc S.Chief Brand Officer
- Bharucha Freddy P.CEO - Beauty
- Davis Jennifer L.CEO - Health Care
- Janzaruk Matthew W.SVP - Chief Accounting Officer
- Jejurikar ShaileshChief Operating Officer
- Raman Sundar G.CEO-Fabric & Home Care
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-07-24
PG Q3 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$21.2B↑ +7.4%
Diluted EPS$1.63↑ +5.8%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $76.1B | $80.2B | $82.0B | $84.0B | $84.3B |
| Gross profit | — | — | — | — | — |
| Operating income | $18.0B | $17.8B | $18.1B | $18.5B | $20.5B |
| Net income | $14.3B | $14.7B | $14.7B | $14.9B | $16.0B |
| Diluted EPS | $5.50 | $5.81 | $5.90 | $6.02 | $6.51 |
| Operating cash flow | $18.4B | $16.7B | $16.8B | $19.8B | $17.8B |
| Free cash flow | $15.6B | $13.6B | $13.8B | $16.5B | $14.0B |
| Gross margin | — | — | — | — | — |
| Operating margin | 23.6% | 22.2% | 22.1% | 22.1% | 24.3% |
| Net margin | 18.8% | 18.4% | 17.9% | 17.7% | 19.0% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.5B | $21.7B | $21.9B | $19.8B | $20.9B | $22.4B | $22.2B | $21.2B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $3.9B | $5.8B | $5.7B | $4.6B | $4.4B | $5.9B | $5.4B | $4.6B |
| Net income | $3.1B | $4.0B | $4.6B | $3.8B | $3.6B | $4.8B | $4.3B | $3.9B |
| Diluted EPS | $1.27 | $1.61 | $1.88 | $1.54 | $1.48 | $1.95 | $1.78 | $1.63 |
| Operating cash flow | $5.8B | $4.3B | $4.8B | $3.7B | $5.0B | $5.4B | $5.0B | $4.0B |
| Free cash flow | $5.0B | $3.3B | $3.9B | $2.8B | $4.0B | $4.2B | $3.8B | $3.0B |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 18.9% | 26.7% | 26.2% | 23.0% | 20.8% | 26.2% | 24.2% | 21.5% |
| Net margin | 15.3% | 18.2% | 21.2% | 19.1% | 17.3% | 21.2% | 19.4% | 18.5% |
Company news
Jul 20, 2026
Jul 19, 2026
Jul 18, 2026
- 2d agoThe Portfolio That Gives You a $2,000 Raise Every Year247wallst.com
- 2d agoHow P&G’s Latest Dividend Hike Amid Cost Cuts Will Impact Procter & Gamble (PG) Investorsfinance.yahoo.com
- 2d agoThe Portfolio That Lets You Cruise Through the News, Unbothered247wallst.com
- 2d ago3 Dividend Stocks That Have Survived Every Market Crash in July247wallst.com
- 2d agoHere’s the Funding It Takes to Keep Learning Forever247wallst.com
- 2d agoIf Volatility Stays Low, Here’s What Happens to DIVO’s Monthly Income247wallst.com
Jul 17, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-09 | Portman Robert Jones | Award | 51 | $0.00 | $0.00 | filing |
| 2026-06-09 | McEvoy Ashley | Award | 202 | $0.00 | $0.00 | filing |
| 2026-06-09 | McCarthy Christine M | Award | 253 | $0.00 | $0.00 | filing |
| 2026-06-09 | Kempczinski Christopher J | Award | 258 | $0.00 | $0.00 | filing |
| 2026-06-09 | JIMENEZ JOSEPH | Award | 320 | $0.00 | $0.00 | filing |
| 2026-06-09 | ARNOLD CRAIG | Award | 202 | $0.00 | $0.00 | filing |
| 2026-03-10 | Portman Robert Jones | Award | 49 | $0.00 | $0.00 | filing |
| 2026-03-10 | Portman Robert Jones | Award | 193 | $0.00 | $0.00 | filing |
| 2026-03-10 | McEvoy Ashley | Award | 161 | $0.00 | $0.00 | filing |
| 2026-03-10 | McCarthy Christine M | Award | 209 | $0.00 | $0.00 | filing |
| 2026-03-10 | Kempczinski Christopher J | Award | 201 | $0.00 | $0.00 | filing |
| 2026-03-10 | JIMENEZ JOSEPH | Award | 273 | $0.00 | $0.00 | filing |
| 2026-03-10 | ARNOLD CRAIG | Award | 161 | $0.00 | $0.00 | filing |
| 2026-02-27 | Francisco Ma. Fatima· CEO - Baby, Fem & Family Care | Sale | 5,249 | $165.29 | $867,607.21 | filing |
| 2026-02-27 | Francisco Ma. Fatima· CEO - Baby, Fem & Family Care | Sale | 130 | $165.30 | $21,489.00 | filing |
| 2026-02-27 | Francisco Ma. Fatima· CEO - Baby, Fem & Family Care | Sale | 120 | $165.31 | $19,837.20 | filing |
| 2026-02-27 | Francisco Ma. Fatima· CEO - Baby, Fem & Family Care | Sale | 50 | $165.32 | $8,266.00 | filing |
| 2026-02-19 | Whaley Susan Street· Chief Legal Officer & Secy | Sale | 1,809 | $159.46 | $288,454.28 | filing |
| 2026-02-13 | Aguilar Moses Victor Javier· Chf Rsch, Dev & Innov Officer | Sale | 15,169 | $162.28 | $2.5M | filing |
| 2026-02-13 | Aguilar Moses Victor Javier· Chf Rsch, Dev & Innov Officer | Option exercise | 15,169 | $91.07 | $1.4M | filing |
| 2026-02-12 | Moeller Jon R· Exec. Chairman of the Board | Sale | 162,232 | $162.45 | $26.4M | filing |
| 2026-02-12 | Moeller Jon R· Exec. Chairman of the Board | Option exercise | 162,232 | $113.23 | $18.4M | filing |
| 2026-02-12 | Coombe Gary A· CEO - Grooming | Sale | 36,093 | $162.33 | $5.9M | filing |
| 2026-02-12 | Coombe Gary A· CEO - Grooming | Option exercise | 36,093 | $78.52 | $2.8M | filing |
| 2026-02-11 | Purushothaman Balaji· Chief Human Resources Officer | Sale | 12,827 | $160.31 | $2.1M | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.